Literature DB >> 29228363

Testing for coccidioidomycosis in emergency departments in Arizona.

Mohammed A Khan1,2, Shane Brady1, Ken K Komatsu1.   

Abstract

Testing practices for coccidioidomycosis in the emergency department are poorly understood. We described characteristics of patients tested for coccidioidomycosis in emergency departments in Arizona and examined coccidioidomycosis testing among community-acquired pneumonia (CAP) patients. Emergency department visit records for patients tested for coccidioidomycosis and CAP patients were extracted from the Arizona hospital discharge database. In sum, 2.8% of CAP patients were tested for coccidioidomycosis. The proportion of patients tested varied substantially by healthcare facility and provider.

Entities:  

Mesh:

Year:  2018        PMID: 29228363     DOI: 10.1093/mmy/myx112

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  3 in total

1.  Characterization of an Uncinocarpus reesii-expressed recombinant tube precipitin antigen of Coccidioides posadasii for serodiagnosis.

Authors:  Jieh-Juen Yu; Eric Holbrook; Yu-Rou Liao; Robert Zarnowski; David R Andes; L Joseph Wheat; Joshua Malo; Chiung-Yu Hung
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

2.  Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis.

Authors:  Amy J Grizzle; Leslie Wilson; David E Nix; John N Galgiani
Journal:  Open Forum Infect Dis       Date:  2020-12-28       Impact factor: 3.835

Review 3.  Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials.

Authors:  John N Galgiani; Lisa F Shubitz; Marc J Orbach; M Alejandra Mandel; Daniel A Powell; Bruce S Klein; Edward J Robb; Mana Ohkura; Devin J Seka; Thomas M Tomasiak; Thomas P Monath
Journal:  J Fungi (Basel)       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.